LOC100506499: A Potential Drug Target and Biomarker (G100506499)
LOC100506499: A Potential Drug Target and Biomarker
LOC100506499 is a protein that has been identified as a potential drug target and biomarker. It is a key regulator of the cell-cycle and has been shown to play a role in various diseases, including cancer. The identification of LOC100506499 as a potential drug target has significant implications for the development of new treatments for these diseases. Additionally, as a biomarker, its levels can be used to monitor disease progression and response to treatment.
Location and Extraction
LOC100506499 is a protein that is expressed in various cell types, including neurons, astrocytes, and cancer cells. It is primarily expressed in the brain and has been shown to be involved in the development and progression of neurodegenerative diseases, as well as in the regulation of cancer cell growth and metastasis.
Disease Interaction
LOC100506499 has been shown to interact with several other proteins, including TP53, which is a well-known tumor suppressor protein. TP53 is a key regulator of the cell-cycle and has been shown to play a role in the regulation of DNA damage repair, as well as in the development of cancer.
In addition to its interaction with TP53, LOC100506499 has also been shown to interact with several other proteins, including the oncogene PDGF-BB. PDGF-BB is a potent tumor suppressor that has been shown to promote the growth and survival of various cancer cells.
The Potential Role of LOC100506499 in Cancer
The identification of LOC100506499 as a potential drug target has significant implications for the treatment of cancer. Cancer is a leading cause of death worldwide and is a complex disease that involves the interplay of multiple factors, including genetic and environmental factors.
LOC100506499 has been shown to play a role in the regulation of cancer cell growth and metastasis. It has been shown to promote the growth and survival of various cancer cells, including those derived from brain tumors.
In addition to its role in cancer cell growth and metastasis, LOC100506499 has also been shown to contribute to the development of cancer. For example, studies have shown that LOC100506499 is overexpressed in various types of cancer, including brain tumors and breast cancer.
The Potential Use of LOC100506499 as a Biomarker
LOC100506499 has also been shown to be a potential biomarker for several types of cancer, including breast and brain tumors. The levels of LOC100506499 have been shown to be elevated in the blood and urine of individuals with various types of cancer, including breast and brain tumors.
In addition to its potential use as a biomarker, LOC100506499 has also been shown to be a good candidate for targeting with small molecules. The identification of small molecules that can interact with LOC100506499 and inhibit its activity has significant implications for the development of new treatments for cancer.
Conclusion
LOC100506499 is a protein that has been identified as a potential drug target and biomarker. Its role in the regulation of the cell-cycle and its involvement in the development and progression of various diseases make it an attractive target for small molecules. Further studies are needed to determine the full extent of LOC100506499's involvement in cancer and to develop new treatments based on its potential as a drug target and biomarker.
Protein Name: Uncharacterized LOC100506499
The "LOC100506499 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100506499 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202 | LOC101593348 | LOC101926887 | LOC101926948 | LOC101926953 | LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026 | LOC101927040 | LOC101927053 | LOC101927060 | LOC101927066 | LOC101927082 | LOC101927108 | LOC101927143 | LOC101927164 | LOC101927166 | LOC101927169 | LOC101927179 | LOC101927188 | LOC101927199 | LOC101927216 | LOC101927243 | LOC101927245 | LOC101927253 | LOC101927263 | LOC101927269 | LOC101927314 | LOC101927369 | LOC101927394 | LOC101927421 | LOC101927476 | LOC101927483 | LOC101927495 | LOC101927518 | LOC101927531 | LOC101927548 | LOC101927550 | LOC101927571 | LOC101927588 | LOC101927598 | LOC101927605 | LOC101927609 | LOC101927627 | LOC101927636 | LOC101927668 | LOC101927712
